{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-119563","form_type":"8-K","ticker":null,"cik":"0001633070","company_name":"Axcella Health Inc.","filed_at":"2023-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.848807+00:00","generated_at":"2026-06-08T00:06:46.047405+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Axcella Health receives Nasdaq delisting notice for late Q3 10-Q filing","bullets":["Nasdaq notified Axcella on Nov 16, 2023 of non-compliance with Listing Rule 5250(c)(1) due to failure to file Q3 2023 Form 10-Q.","The Nasdaq Hearings Panel will consider the matter and decide on continued listing on The Nasdaq Global Market.","If delisted, AXLA shares could be subject to removal from Nasdaq, affecting liquidity and trading.","Company faces risk of losing Nasdaq listing unless it regains compliance with SEC filing requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-119563","json":"https://secwatch.observer/filing/0001104659-23-119563.json","markdown":"https://secwatch.observer/filing/0001104659-23-119563.md","text":"https://secwatch.observer/filing/0001104659-23-119563.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923119563/0001104659-23-119563-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923119563/tm2331043d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T00:06:46.047405+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58d0aae572f4bbca0020aed8e6a61783911cfdbd","claim":"Axcella Health Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"November 16, 2023, Axcella Health Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with the continued listing requirements of Nasdaq Listing Rule 5250(c)(1) because its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 had not yet been filed with the Securities and Exchange Commission (“SEC”). The Nasdaq Hearings Panel (the “Panel”) will consider this matter in its decision regarding the Company’s continued listing on The Nasdaq Global Market. Forward Lo","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465923119563/0001104659-23-119563-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}